Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
The prenatal diagnosis of anencephaly and spina bifida (neural tube defect, NTD) through amniotic fluid analysis for alpha-fetoprotein (AFP) is gradually gaining clinical recognition. AFP concentrations were determined in 237 amniotic fluids from normal pregnancies ranging between 7 and 42 weeks of gestation. A steady decline in AFP from 26 mug/ml at 7-9 weeks to 155 ng/ml at term is observed. AFP concentration was determined in 35 amniotic fluids from 33 confirmed neural tube defective pregnancies. In 14 cases where amniotic fluid was examined prior to the 26th week of gestation. AFP was markedly elevated when compared with the normal range of the same gestational period. In 21 amniotic fluids past the 26th week, 17 cases (85-) had markedly elevated AFP levels; however, 2 cases of anencephaly, 1 of spina bifida, and 1 of hydrocephaly gave levels within the normal range. It is concluded that elevated AFP in the amniotic fluid is a reliable but nonspecific marker for open neural tube defects prior to the 26th week of pregnancy, but may become normal after the 26th week in a small percentage of patients.
D000653:Amniotic Fluid / Q000032:analysis*; D000757:Anencephaly / Q000175:diagnosis*; D005260:Female; D005326:Fetal Proteins / Q000032:analysis*; D006801:Humans; D005779:Immunodiffusion; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011863:Radioimmunoassay; D016135:Spinal Dysraphism / Q000175:diagnosis*; D013997:Time Factors; D000509:alpha-Fetoproteins / Q000032:analysis*
D005326:Fetal Proteins; D000509:alpha-Fetoproteins